The Reserve Bank on Friday raised the inflation projection for current fiscal year to 4.8 per cent from 4.5 per cent with Governor Shaktikanta Das saying lingering food price pressures are likely to keep headline inflation elevated in the December
India’s forex reserves increased by $1.51 billion to $658.09 billion for the week ended November 29, the RBI said on Friday. Photograph: Lisa Marie David/Reuters The overall reserves had dropped by $1.31 billion to $656.58 billion in the previous reporting
To ease the potential liquidity stress, the Reserve Bank on Friday slashed Cash Reserve Ratio (CRR) by 50 basis points to 4 per cent, a move that would unlock Rs 1.16 lakh crore bank funds. The RBI on May 4,
1 / 11 Garden Reach Shipbuilders | State-run company said it has signed a contract for the construction and delivery of the second 7,500 Deadweight Tonnage (DWT) Multi-Purpose Vessel (MPV) in a series of four additional vessels. The agreement was
Sylph Technologies share price was locked at 10% upper circuit limit of ₹1.27 on Friday, December 6, after the company’s board of directors approved fundraising plans through rights issue of shares. Sylph Technologies shares opened at ₹1.25 apiece as against
Chief Economic Advisor V Anantha Nageswaran on Thursday said economic activity in some sectors have picked up pace during October-November and a GDP growth of 6.5-7 per cent in the current fiscal is feasible. Photograph: Anushree Fadnavis/Reuters He also said
Gold buying by central banks surged to 60 tonnes in October, mainly led by the Reserve Bank of India (RBI) which added 27 tonnes of the precious metal to its reserves, the World Gold Council (WGC) said on Thursday. Photograph:
Sorry! The requested page could not be found. We apologize for the inconvenience, but the page you tried to access does not exist on this location. You have either misspelled the filename or the link you used is out-dated. Please
Benchmark equity indices Sensex and Nifty maintained their winning run on Thursday, rising 1 per cent, propelled by buying in IT stocks amid a rally in the US markets and fresh foreign fund inflows. Photograph: Shailesh Andrade/Reuters Rallying for the
Aurobindo Pharma Ltd.’s wholly-owned subsidiary, Eugia Pharma Specialities Ltd., has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Pazopanib Tablets (200 mg). These tablets are bioequivalent and therapeutically equivalent to the reference listed
